These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32209043)

  • 1. Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review.
    Raghuvanshi R; Bharate SB
    Curr Top Med Chem; 2020; 20(12):1124-1135. PubMed ID: 32209043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development.
    Ruan BF; Zhu HL
    Curr Med Chem; 2012; 19(16):2652-64. PubMed ID: 22506770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic Bryostatin Derivatives from the South China Sea Bryozoan Bugula neritina.
    Yu HB; Yang F; Li YY; Gan JH; Jiao WH; Lin HW
    J Nat Prod; 2015 May; 78(5):1169-73. PubMed ID: 25932671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine natural products: bryostatins in preclinical and clinical studies.
    Kollár P; Rajchard J; Balounová Z; Pazourek J
    Pharm Biol; 2014 Feb; 52(2):237-42. PubMed ID: 24033119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core.
    Kraft MB; Poudel YB; Kedei N; Lewin NE; Peach ML; Blumberg PM; Keck GE
    J Am Chem Soc; 2014 Sep; 136(38):13202-8. PubMed ID: 25207434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, analytical measurements, and cell line studies of the iron-bryostatin-1 complex.
    Plummer S; Manning T; Baker T; McGreggor T; Patel M; Wylie G; Phillips D
    Bioorg Med Chem Lett; 2016 May; 26(10):2489-2497. PubMed ID: 27068183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The design, computer modeling, solution structure, and biological evaluation of synthetic analogs of bryostatin 1.
    Wender PA; DeBrabander J; Harran PG; Jimenez JM; Koehler MF; Lippa B; Park CM; Siedenbiedel C; Pettit GR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6624-9. PubMed ID: 9618462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships.
    Kedei N; Kraft MB; Keck GE; Herald CL; Melody N; Pettit GR; Blumberg PM
    J Nat Prod; 2015 Apr; 78(4):896-900. PubMed ID: 25808573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
    Kedei N; Lewin NE; Géczy T; Selezneva J; Braun DC; Chen J; Herrmann MA; Heldman MR; Lim L; Mannan P; Garfield SH; Poudel YB; Cummins TJ; Rudra A; Blumberg PM; Keck GE
    ACS Chem Biol; 2013 Apr; 8(4):767-77. PubMed ID: 23369356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.
    Staveness D; Abdelnabi R; Near KE; Nakagawa Y; Neyts J; Delang L; Leyssen P; Wender PA
    J Nat Prod; 2016 Apr; 79(4):680-4. PubMed ID: 26900711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin.
    Irie K; Yanagita RC
    Chem Rec; 2014 Apr; 14(2):251-67. PubMed ID: 24677503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the C26 Methyl Substituent from the Bryostatin Analogue Merle 23 Has Negligible Impact on Its Biological Profile and Potency.
    Zhao X; Kedei N; Michalowski A; Lewin NE; Keck GE; Blumberg PM
    Chembiochem; 2018 May; 19(10):1049-1059. PubMed ID: 29517836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical development of the bryostatins.
    Clamp A; Jayson GC
    Anticancer Drugs; 2002 Aug; 13(7):673-83. PubMed ID: 12187323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes.
    Ryckbosch SM; Wender PA; Pande VS
    Nat Commun; 2017 Feb; 8(1):6. PubMed ID: 28232750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.
    DeChristopher BA; Fan AC; Felsher DW; Wender PA
    Oncotarget; 2012 Jan; 3(1):58-66. PubMed ID: 22308267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery.
    Tian XR; Tang HF; Tian XL; Hu JJ; Huang LL; Gustafson KR
    Future Med Chem; 2018 Jun; 10(12):1497-1514. PubMed ID: 29788787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved protein kinase C affinity through final step diversification of a simplified salicylate-derived bryostatin analog scaffold.
    Wender PA; Staveness D
    Org Lett; 2014 Oct; 16(19):5140-3. PubMed ID: 25238640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications.
    Wu R; Chen H; Chang N; Xu Y; Jiao J; Zhang H
    Chemistry; 2020 Jan; 26(6):1166-1195. PubMed ID: 31479550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and clinical biology of the bryostatins.
    Mutter R; Wills M
    Bioorg Med Chem; 2000 Aug; 8(8):1841-60. PubMed ID: 11003129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.